JP2008540398A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540398A5
JP2008540398A5 JP2008509538A JP2008509538A JP2008540398A5 JP 2008540398 A5 JP2008540398 A5 JP 2008540398A5 JP 2008509538 A JP2008509538 A JP 2008509538A JP 2008509538 A JP2008509538 A JP 2008509538A JP 2008540398 A5 JP2008540398 A5 JP 2008540398A5
Authority
JP
Japan
Prior art keywords
oligosaccharide
unit
mannose
formula
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008509538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540398A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/001703 external-priority patent/WO2006120576A2/en
Publication of JP2008540398A publication Critical patent/JP2008540398A/ja
Publication of JP2008540398A5 publication Critical patent/JP2008540398A5/ja
Withdrawn legal-status Critical Current

Links

JP2008509538A 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原 Withdrawn JP2008540398A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67828905P 2005-05-06 2005-05-06
PCT/IB2006/001703 WO2006120576A2 (en) 2005-05-06 2006-05-08 Immunogens for meningitidis-a vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013079295A Division JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Publications (2)

Publication Number Publication Date
JP2008540398A JP2008540398A (ja) 2008-11-20
JP2008540398A5 true JP2008540398A5 (https=) 2009-06-25

Family

ID=36942242

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008509538A Withdrawn JP2008540398A (ja) 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原
JP2013079295A Expired - Fee Related JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013079295A Expired - Fee Related JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Country Status (15)

Country Link
US (1) US8062641B2 (https=)
EP (1) EP1885734B1 (https=)
JP (2) JP2008540398A (https=)
CN (1) CN101282984B (https=)
AU (1) AU2006245440B2 (https=)
BR (1) BRPI0611447A2 (https=)
CA (1) CA2606890C (https=)
ES (1) ES2533248T3 (https=)
MX (1) MX2007013881A (https=)
NZ (1) NZ563940A (https=)
PL (1) PL1885734T3 (https=)
PT (1) PT1885734E (https=)
RU (1) RU2412944C2 (https=)
WO (1) WO2006120576A2 (https=)
ZA (1) ZA200710558B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US8398983B2 (en) 2005-06-27 2013-03-19 Glaxosmithkline Biologicals, S.A. Immunogenic composition
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
GB0700562D0 (en) * 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
AU2014200640B2 (en) * 2007-01-11 2016-06-16 Glaxosmithkline Biologicals Sa Modified saccharides
US8828952B2 (en) 2007-10-16 2014-09-09 Progen Pharmaceuticals Limited Sulfated oligosaccharide derivatives
KR101594228B1 (ko) 2010-08-23 2016-02-15 와이어쓰 엘엘씨 네이세리아 메닌기티디스 rLP2086 항원의 안정한 제제
ES2744471T3 (es) 2010-09-04 2020-02-25 Glaxosmithkline Biologicals Sa Ensayos de anticuerpos bactericidas para evaluar la inmunogenia y la potencia de vacunas de sacárido capsular meningocócico
NZ607224A (en) 2010-09-10 2014-11-28 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
CN102417521B (zh) * 2010-09-28 2014-05-07 中国医学科学院医药生物技术研究所 一种非环核苷类抗病毒药物磷酸单酯化合物的制备方法
WO2012103444A2 (en) * 2011-01-28 2012-08-02 Purdue Research Foundation Immunogenic compositions and reagents for preparing
US9616139B2 (en) 2011-07-12 2017-04-11 The General Hospital Corporation Conjugating amines
RU2476444C1 (ru) * 2011-07-15 2013-02-27 Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) СПОСОБ ПОЛУЧЕНИЯ КОНЪЮГАТА НОНА-β-(1→3)-ГЛЮКОЗИДА С БЫЧЬИМ СЫВОРОТОЧНЫМ АЛЬБУМИНОМ СКВАРАТНЫМ МЕТОДОМ
MX359256B (es) 2012-03-09 2018-09-19 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
WO2014130613A2 (en) * 2013-02-22 2014-08-28 Amgen Inc. Carbohydrate phosphonate derivatives as modulators of glycosylation
US9802987B2 (en) 2013-03-08 2017-10-31 Pfizer Inc. Immunogenic fusion polypeptides
HK1224300A1 (zh) * 2013-07-07 2017-08-18 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. 合成针对1型肺炎链球菌的疫苗
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
JP6526692B2 (ja) * 2014-02-25 2019-06-05 エムエスディー ウェルカム トラスト ヒルマン ラボラトリーズ プライベート リミテッドMsd Wellcome Trust Hilleman Laboratories Pvt.Ltd. 髄膜炎菌(Neisseria meningitidis)血清型Xの新規の合成オリゴマー及びその調製方法
BR112017006447A2 (pt) * 2014-10-09 2017-12-12 Msd Wellcome Trust Hilleman Laboratories Pvt Ltd processo de conjugação e conjugados sintéticos de oligossacarídeo-proteína obtidos dos mesmos
AU2016221318B2 (en) 2015-02-19 2020-06-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
KR102906912B1 (ko) 2016-09-02 2026-01-05 사노피 파스퇴르 인크 네이세리아 메닌기티디스 백신
AU2018215585B2 (en) 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2018173068A1 (en) * 2017-03-21 2018-09-27 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. A novel synthetic neisseria meningitidis serogroup a oligomer and process for synthesizing thereof
CA3120451A1 (en) 2018-11-22 2020-05-28 Idorsia Pharmaceuticals Ltd Stable vaccine against clostridium difficile with modifications to the ps-ii saccharide
EP4034157A1 (en) 2019-09-27 2022-08-03 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN118178643B (zh) * 2024-04-28 2024-11-29 亚培烯科技(上海)有限公司 饱和α烯烃低聚物作为佐剂在动物疫苗中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US6114309A (en) * 1997-11-21 2000-09-05 Incara Research Laboratories Combinatorial library of moenomycin analogs and methods of producing same
JP4774496B2 (ja) * 2001-06-14 2011-09-14 独立行政法人産業技術総合研究所 α−マンノシダーゼ
PT1777236T (pt) * 2002-03-26 2017-02-13 Glaxosmithkline Biologicals Sa Sacáridos modificados possuindo estabilidade melhorada em água para utilização como um medicamento
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
ES2461350T3 (es) * 2003-01-30 2014-05-19 Novartis Ag Vacunas inyectables contra múltiples serogrupos de meningococos
RU2250113C2 (ru) * 2003-06-04 2005-04-20 Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова Российской академии наук Способ приготовления бивалентной вакцины для профилактики менингококковой инфекции

Similar Documents

Publication Publication Date Title
JP2008540398A5 (https=)
RU2412944C2 (ru) Иммуногены для вакцин против менингита а
JP2013136639A5 (https=)
JP2010515718A5 (https=)
TWI633112B (zh) 醣類-醣脂類結合性疫苗
JP2010132925A5 (https=)
JP2012017342A5 (https=)
Enotarpi et al. A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
CN107709343B (zh) 针对肺炎链球菌血清型5的疫苗
AU2014289342B2 (en) Synthetic vaccines against Streptococcus pneumoniae type 1
Torres‐Sanchez et al. Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A
Wright et al. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease
JPH0885703A (ja) 臓器移行性を有する多糖誘導体および薬物担体
Sukhova et al. Synthesis and preliminary immunological evaluation of a pseudotetrasaccharide related to a repeating unit of the Streptococcus pneumoniae serotype 6A capsular polysaccharide
JP4850377B2 (ja) リボース−リビトールホスフェートのオリゴ糖誘導体とそれを含むワクチン
AU2021331377B2 (en) Pentavalent vaccine against neisseria meningitidis comprising a synthetic men a antigen
CA3131741A1 (en) Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines
JP2024180376A (ja) 化合物、免疫増強剤、ワクチン組成物及び粘膜ワクチン組成物
HK40113822A (zh) 预防/治疗铜绿假单胞菌感染
Auberger Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens for antimeningococcal glycoconjugate vaccines
CN119095871A (zh) 预防/治疗铜绿假单胞菌感染
Koutha Synthetic studies toward pseudopentasaccharide repeating unit of Streptococcus pneumoniae zwitterionic polysaccharide